Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 May;69(5):1176–1184. doi: 10.1172/JCI110554

Evidence for Two Tissue-specific Pathways for In Vivo Thyroxine 5′-Deiodination in the Rat

J Enrique Silva 1,2,3, Jack L Leonard 1,2,3, Frank R Crantz 1,2,3, P Reed Larsen 1,2,3
PMCID: PMC370183  PMID: 7068853

Abstract

Propylthiouracil (PTU) is a well known inhibitor of thyroxine (T4) to triiodothyronine (T3) conversion as evidenced by its effect in several in vitro systems and by the decrease in serum T3 caused by this drug in either rats or man receiving T4 replacement. However, the failure of PTU to decrease the intrapituitary T3 concentration and to completely blunt the serum T3 concentration in T4-replaced athyreotic rats suggest that there may be a PTU-insensitive pathway of T4 to T3 conversion in some tissues. To address this question, we have studied the in vivo effect of PTU treatment on the generation of [125I]T3 from [125I]T4 in the serum and cerebral cortex (Cx), cerebellum (Cm), liver (L), and anterior pituitary (P) of euthyroid rats. Whereas PTU decreased the concentration of [125I]T3 in the serum, L homogenates, and L nuclei after [125I]T4, it did not affect the concentration of [125I]T3 in homogenates or nuclei of Cx, Cm, or P. Iopanoic acid pretreatment significantly reduced the [125I]T3 concentration in serum, homogenates, and cell nuclei of all these organs. Neither agent affected the metabolism or tissue distribution of simultaneously injected [131I]T3. The presence of PTU in these tissues was evaluated by in vitro assessment of iodothyronine 5′-deiodinating activity using both [125I]rT3 and [125I]T4 as substrates. In agreement with the in vivo findings, generation of [125I]T3 from T4 in vitro was not affected by PTU in Cx, Cm, P but it was inhibited by 76% in L. However, rT3 5′-deiodination, known to be sensitive to PTU in these tissues, was inhibited in all four indicating that the PTU given in vivo was present in significant amounts. These results demonstrate that in rat Cx, Cm, and P unlike liver, PTU does not inhibit T4 to T3 conversion in vivo despite the presence of the drug in the tissues in amounts that significantly inhibit reverse T3 5′-deiodination. These results show that in vivo 5′-deiodination of T4 proceeds via a PTU-insensitive pathway in the central nervous system and pituitary, while this pathway is not quantitatively important in the L. This mechanism accounts for the “locally generated” T3 in central nervous system and pituitary and could also provide the approximately one-third of extrathyroidally produced T3 not blocked by PTU administration in athyreotic T4-replaced rat.

Full text

PDF
1176

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernal J., Escobar del Rey F. Inhibition by propylthiouracil of the extrathyroidal formation of triiodothyronine from thyroxine. Acta Endocrinol (Copenh) 1974 Oct;77(2):276–281. doi: 10.1530/acta.0.0770276. [DOI] [PubMed] [Google Scholar]
  2. Cheron R. G., Kaplan M. M., Larsen P. R. Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. J Clin Invest. 1979 Nov;64(5):1402–1414. doi: 10.1172/JCI109598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Crantz F. R., Larsen P. R. Rapid thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat cerebral cortex and cerebellum. J Clin Invest. 1980 Apr;65(4):935–938. doi: 10.1172/JCI109749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crantz F. R., Silva J. E., Larsen P. R. An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology. 1982 Feb;110(2):367–375. doi: 10.1210/endo-110-2-367. [DOI] [PubMed] [Google Scholar]
  5. Dratman M. B., Crutchfield F. L. Synaptosomal [125I]triiodothyronine after intravenous [125I]thyroxine. Am J Physiol. 1978 Dec;235(6):E638–E647. doi: 10.1152/ajpendo.1978.235.6.E638. [DOI] [PubMed] [Google Scholar]
  6. Frumess R. D., Larsen P. R. Correlation of serum triiodothyronine (T3) and thyroxine (T4) with biologic effects of thyroid hormone replacement in propylthiouracil-treated rats. Metabolism. 1975 Apr;24(4):547–554. doi: 10.1016/0026-0495(75)90079-7. [DOI] [PubMed] [Google Scholar]
  7. Kaplan M. M., Tatro J. B., Breitbart R., Larsen P. R. Comparison of thyroxine and 3,3',5'-triiodothyronine metabolism in rat kidney and liver homogenates. Metabolism. 1979 Nov;28(11):1139–1146. doi: 10.1016/0026-0495(79)90153-7. [DOI] [PubMed] [Google Scholar]
  8. Kaplan M. M. Thyroxine 5'-monodeiodination in rat anterior pituitary homogenates. Endocrinology. 1980 Feb;106(2):567–576. doi: 10.1210/endo-106-2-567. [DOI] [PubMed] [Google Scholar]
  9. Kaplan M. M., Yaskoski K. A. Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates. J Clin Invest. 1980 Sep;66(3):551–562. doi: 10.1172/JCI109887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Larsen P. R., Dick T. E., Markovitz B. P., Kaplan M. M., Gard T. G. Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats. J Clin Invest. 1979 Jul;64(1):117–128. doi: 10.1172/JCI109430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Larsen P. R., Frumess R. D. Comparison of the biological effects of thyroxine and triiodothyronine in the rat. Endocrinology. 1977 Apr;100(4):980–988. doi: 10.1210/endo-100-4-980. [DOI] [PubMed] [Google Scholar]
  12. Larsen P. R., Silva J. E., Kaplan M. M. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev. 1981 Winter;2(1):87–102. doi: 10.1210/edrv-2-1-87. [DOI] [PubMed] [Google Scholar]
  13. Leonard J. L., Rosenberg I. N. Characterization of essential enzyme sulfhydryl groups of thyroxine 5'-deiodinase from rat kidney. Endocrinology. 1980 Feb;106(2):444–451. doi: 10.1210/endo-106-2-444. [DOI] [PubMed] [Google Scholar]
  14. Leonard J. L., Rosenberg I. N. Iodothyronine 5'-deiodinase from rat kidney: substrate specificity and the 5'-deiodination of reverse triiodothyronine. Endocrinology. 1980 Nov;107(5):1376–1383. doi: 10.1210/endo-107-5-1376. [DOI] [PubMed] [Google Scholar]
  15. Leonard J. L., Rosenberg I. N. Thyroxine 5'-deiodinase activity of rat kidney: observations on activation by thiols and inhibition by propylthiouracil. Endocrinology. 1978 Dec;103(6):2137–2144. doi: 10.1210/endo-103-6-2137. [DOI] [PubMed] [Google Scholar]
  16. Melmed S., Nelson M., Kaplowitz N., Yamada T., Hershman J. M. Glutathione-dependent thyroxine 5'-monodeiodination modulates growth hormone production by cultured nonthyrotropic rat pituitary cells. Endocrinology. 1981 Mar;108(3):970–976. doi: 10.1210/endo-108-3-970. [DOI] [PubMed] [Google Scholar]
  17. Oppenheimer J. H., Schwartz H. L., Surks M. I., Koerner D., Dillmann W. H. Nuclear receptors and the initiation of thyroid hormone action. Recent Prog Horm Res. 1976;32:529–565. doi: 10.1016/b978-0-12-571132-6.50029-4. [DOI] [PubMed] [Google Scholar]
  18. Oppenheimer J. H., Schwartz H. L., Surks M. I. Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine. An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active thyroid hormone. J Clin Invest. 1972 Sep;51(9):2493–2497. doi: 10.1172/JCI107063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Oppenheimer J. H., Schwartz H. L., Surks M. I. Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen, and testis. Endocrinology. 1974 Sep;95(3):897–903. doi: 10.1210/endo-95-3-897. [DOI] [PubMed] [Google Scholar]
  20. Oppenheimer J. H. Thyroid hormone action at the cellular level. Science. 1979 Mar 9;203(4384):971–979. doi: 10.1126/science.218285. [DOI] [PubMed] [Google Scholar]
  21. Silva J. E., Dick T. E., Larsen P. R. The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3'-triiodothyronine in pituitary, liver, and kidney of euthyroid rats. Endocrinology. 1978 Oct;103(4):1196–1207. doi: 10.1210/endo-103-4-1196. [DOI] [PubMed] [Google Scholar]
  22. Silva J. E., Larsen P. R. Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release. J Clin Invest. 1978 May;61(5):1247–1259. doi: 10.1172/JCI109041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Silva J. E., Larsen P. R. Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science. 1977 Nov 11;198(4317):617–620. doi: 10.1126/science.199941. [DOI] [PubMed] [Google Scholar]
  24. Visser T. J., Leonard J. L., Kaplan M. M., Larsen P. R. Different pathways of iodothyronine 5'-deiodination in rat cerebral cortex. Biochem Biophys Res Commun. 1981 Aug 31;101(4):1297–1304. doi: 10.1016/0006-291x(81)91588-6. [DOI] [PubMed] [Google Scholar]
  25. Zimmerman C. J., Izumi M., Larsen P. R. Isolation of labeled triiodothyronine from serum using affinity chromatography: application to the extimation of the peripheral T4 to T3 conversion in rats. Metabolism. 1978 Mar;27(3):303–313. doi: 10.1016/0026-0495(78)90110-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES